As global markets navigate mixed performances and economic uncertainties, investors are increasingly turning their attention to stable income sources like dividend stocks. In this context, understanding what makes a strong dividend stock—such as consistent payouts and robust financial health—becomes crucial for those looking to bolster their portfolios amidst fluctuating indices and economic shifts.
Name |
Dividend Yield |
Dividend Rating |
Tsubakimoto Chain (TSE:6371) |
4.09% |
★★★★★★ |
Southside Bancshares (NYSE:SBSI) |
4.61% |
★★★★★★ |
Guangxi LiuYao Group (SHSE:603368) |
3.48% |
★★★★★★ |
Padma Oil (DSE:PADMAOIL) |
7.49% |
★★★★★★ |
GakkyushaLtd (TSE:9769) |
4.38% |
★★★★★★ |
China South Publishing & Media Group (SHSE:601098) |
3.89% |
★★★★★★ |
FALCO HOLDINGS (TSE:4671) |
6.38% |
★★★★★★ |
Premier Financial (NasdaqGS:PFC) |
4.89% |
★★★★★★ |
E J Holdings (TSE:2153) |
3.82% |
★★★★★★ |
Citizens & Northern (NasdaqCM:CZNC) |
6.07% |
★★★★★★ |
Click here to see the full list of 1972 stocks from our Top Dividend Stocks screener.
We’ll examine a selection from our screener results.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Kyung Nong Corporation is involved in the manufacture and sale of agricultural chemicals in South Korea, with a market cap of ₩161.68 billion.
Operations: Kyung Nong Corporation generates revenue primarily from its Agrochemical segment, amounting to ₩207.09 billion, and its Fertilizer Business segment, contributing ₩108.15 billion.
Dividend Yield: 7.2%
Kyung Nong’s dividend yield of 7.18% ranks in the top 25% of the Korean market, suggesting an attractive income opportunity despite a volatile history with dividends not consistently growing over the past decade. The company’s dividends are well-covered by earnings and cash flows, with payout ratios of 70.4% and 43.2%, respectively, indicating sustainability. However, its unstable track record may concern investors seeking reliable income streams.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Al Hammadi Holding Company is a healthcare group that offers a range of medical services in the Kingdom of Saudi Arabia, with a market cap of SAR6.16 billion.
Operations: Al Hammadi Holding Company generates revenue through its Medical Services segment, contributing SAR935.68 million, and its Pharmaceutical Products segment, adding SAR199.10 million.
Dividend Yield: 3.6%
Al Hammadi Holding’s dividend yield of 3.64% is below the top 25% of dividend payers in Saudi Arabia, and its dividends have been volatile over the past decade. Despite this, dividends are covered by earnings and cash flows with payout ratios of 68.7% and 60.1%, respectively, indicating sustainability. The stock trades at a good value compared to peers and industry standards, though its unstable dividend history may deter income-focused investors seeking reliability.